Meringue? No, you're not wrong: TxCell outlines unusual Ovasave delivery method
TxCell is working on new ways of delivering its Crohn's disease therapy Ovasave that will replace the somewhat unusual method it is using in clinical trials.
Archives for March 22, 2016
Lonza: More pharmas among top customers in 2015; Strong franc could erode Swiss industry
Drug companies were a more important source of revenue for Lonza in 2015 than in previous years with four of its five biggest spending customers coming from the pharmaceutical sector.
Korea stock? Celltrion stores Remicade biosimilar but minimises risks
Celltrion’s supply chain and warehousing procedures ensure the safe storage of Remicade biosimilars as demand fluctuates across markets, the drugmaker says.